Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD-CAA Prevention (KD-CAAP) trial
Eleftheriou D., Connon R., Tulloh R., Martin N., Kucera F., Christov G., Kahn R., Mossberg M., Nordenhall C., Bailhache M., Palmu S., Webb C., McCrossan B., Herberg J., Collaco-Moraes Y., McCormack R., Stone J., Hunter R., Walker AS., Brogan P.